Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. InfuSystems Holdings's Revenue for the
three
months ended in Mar. 2026 was $33.7 Mil. InfuSystems Holdings's average Accounts Receivable for the
three
months ended in Mar. 2026 was $23.4 Mil.
Hence, InfuSystems Holdings's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.44.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
InfuSystems Holdings Receivables Turnover Related Terms
InfuSystems Holdings Receivables Turnover Historical Data
* Premium members only.
The historical data trend for InfuSystems Holdings's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INFU vs QTRX, LUCD, APYX: Receivables Turnover Comparison
For the Medical Devices subindustry, InfuSystems Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InfuSystems Holdings (INFU) has a Receivables Turnover of 1.44 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on InfuSystems Holdings and its competitors. According to the industry distribution chart, InfuSystems Holdings ranks #358 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 44.1%.
Is InfuSystems Holdings' Receivables Turnover too high?
InfuSystems Holdings' current Receivables Turnover is 1.44. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. InfuSystems Holdings' value of 1.44 is 73.9% below this industry median. Based on the distribution chart, InfuSystems Holdings ranks #358 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, InfuSystems Holdings has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' Receivables Turnover compare to QTRX and LUCD?
According to the Medical Devices & Instruments industry distribution chart, InfuSystems Holdings ranks #358 out of 812 companies for Receivables Turnover. This puts InfuSystems Holdings in the upper half of its industry. The industry median Receivables Turnover is 5.51. InfuSystems Holdings' value of 1.44 is 73.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InfuSystems Holdings's current Receivables Turnover of 1.44 is 73.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on InfuSystems Holdings and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InfuSystems Holdings's current Receivables Turnover is 1.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Fairly Valued. The stock's GF Value™ is $9.45, compared to a current price of $9.24 — trading 2.2% below its estimated fair value. The current Receivables Turnover is 1.44 and 73.9% below the Medical Devices & Instruments industry median of 5.51. InfuSystems Holdings' overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current Receivables Turnover is 1.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InfuSystems Holdings (INFU) Overvalued in 2026?
Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be undervalued.
The current stock price of $9.24 is trading 2.2% below its estimated GF Value™ of $9.45.
GuruFocus considers InfuSystems Holdings to be Fairly Valued.
Key valuation signals for INFU:
Receivables Turnover: 1.44
GF Value™: $9.45 vs. price of $9.24 (2.2% below fair value)
Industry Position: 73.9% below the Medical Devices & Instruments median (#358 of 812)
No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
88GF Score
Get the complete analysis for INFU
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INFU has been successfully added to your 
